Cannabinoids For Fibromyalgia: An Updated Systematic Review
View ORCID ProfileJean Claude Scicluna, Giuseppe Di Giovanni
doi: https://doi.org/10.1101/2022.05.17.22275200
Jean Claude Scicluna
1Laboratory of Neurophysiology, Department of Physiology and Biochemistry, Faculty of Medicine and Surgery, University of Malta, Msida, Malta
Giuseppe Di Giovanni
1Laboratory of Neurophysiology, Department of Physiology and Biochemistry, Faculty of Medicine and Surgery, University of Malta, Msida, Malta
2School of Biosciences, Neuroscience Division, Cardiff University, Cardiff, UK
Data Availability
All data produced in the present work are contained in the manuscript.
Posted May 20, 2022.
Cannabinoids For Fibromyalgia: An Updated Systematic Review
Jean Claude Scicluna, Giuseppe Di Giovanni
medRxiv 2022.05.17.22275200; doi: https://doi.org/10.1101/2022.05.17.22275200
Subject Area
Subject Areas
- Addiction Medicine (353)
- Allergy and Immunology (675)
- Anesthesia (182)
- Cardiovascular Medicine (2674)
- Dermatology (226)
- Emergency Medicine (404)
- Epidemiology (12292)
- Forensic Medicine (10)
- Gastroenterology (768)
- Genetic and Genomic Medicine (4144)
- Geriatric Medicine (388)
- Health Economics (682)
- Health Informatics (2685)
- Health Policy (1008)
- Hematology (365)
- HIV/AIDS (857)
- Medical Education (401)
- Medical Ethics (110)
- Nephrology (443)
- Neurology (3925)
- Nursing (212)
- Nutrition (584)
- Oncology (2064)
- Ophthalmology (592)
- Orthopedics (243)
- Otolaryngology (306)
- Pain Medicine (251)
- Palliative Medicine (75)
- Pathology (473)
- Pediatrics (1126)
- Primary Care Research (461)
- Public and Global Health (6566)
- Radiology and Imaging (1415)
- Respiratory Medicine (874)
- Rheumatology (413)
- Sports Medicine (344)
- Surgery (454)
- Toxicology (54)
- Transplantation (189)
- Urology (169)